male or female subject must have be between 2 and 60 year of age at the time of the enrollment in the phase 3 double-blind study 13110a/ov1012/nct00518713 or between 2 and 30 year of age at the time of the enrollment in the phase 2 double-blind study 13108a/ov1002/nct00162981 study 